{
     "PMID": "17078926",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20070530",
     "LR": "20170219",
     "IS": "0006-3002 (Print) 0006-3002 (Linking)",
     "VI": "1768",
     "IP": "4",
     "DP": "2007 Apr",
     "TI": "G protein-coupled receptors in major psychiatric disorders.",
     "PG": "976-93",
     "AB": "Although the molecular mechanisms underlying psychiatric illnesses such as depression, bipolar disorder and schizophrenia remain incompletely understood, there is increasing clinical, pharmacologic, and genetic evidence that G protein-coupled receptors (GPCRs) play critical roles in these disorders and their treatments. This perspectives paper reviews and synthesizes the available data. Dysfunction of multiple neurotransmitter and neuropeptide GPCRs in frontal cortex and limbic-related regions, such as the hippocampus, hypothalamus and brainstem, likely underlies the complex clinical picture that includes cognitive, perceptual, affective and motoric symptoms. The future development of novel agents targeting GPCR signaling cascades remains an exciting prospect for patients refractory to existing therapeutics.",
     "FAU": [
          "Catapano, Lisa A",
          "Manji, Husseini K"
     ],
     "AU": [
          "Catapano LA",
          "Manji HK"
     ],
     "AD": "Laboratory of Molecular Pathophysiology, Mood and Anxiety Disorders Program, National Institute of Mental Health, NIH, HHS, Bethesda, MD 20892, USA. catapanol@mail.nih.gov",
     "LA": [
          "eng"
     ],
     "GR": [
          "Z01 MH002831-03/MH/NIMH NIH HHS/United States",
          "Z01 MH002847-02/MH/NIMH NIH HHS/United States",
          "Intramural NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, N.I.H., Intramural",
          "Research Support, Non-U.S. Gov't",
          "Review"
     ],
     "DEP": "20061003",
     "PL": "Netherlands",
     "TA": "Biochim Biophys Acta",
     "JT": "Biochimica et biophysica acta",
     "JID": "0217513",
     "RN": [
          "0 (Receptors, G-Protein-Coupled)"
     ],
     "SB": "IM",
     "MH": [
          "Drug Design",
          "Humans",
          "Mood Disorders/*etiology/metabolism",
          "Receptors, G-Protein-Coupled/drug effects/*metabolism",
          "Schizophrenia/*etiology/metabolism"
     ],
     "RF": "249",
     "PMC": "PMC2366056",
     "MID": [
          "NIHMS21043"
     ],
     "EDAT": "2006/11/03 09:00",
     "MHDA": "2007/05/31 09:00",
     "CRDT": [
          "2006/11/03 09:00"
     ],
     "PHST": [
          "2006/07/20 00:00 [received]",
          "2006/09/28 00:00 [accepted]",
          "2006/11/03 09:00 [pubmed]",
          "2007/05/31 09:00 [medline]",
          "2006/11/03 09:00 [entrez]"
     ],
     "AID": [
          "S0005-2736(06)00384-1 [pii]",
          "10.1016/j.bbamem.2006.09.025 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Biochim Biophys Acta. 2007 Apr;1768(4):976-93. doi: 10.1016/j.bbamem.2006.09.025. Epub 2006 Oct 3.",
     "term": "hippocampus"
}